What is Asico?
Asico functions as a critical component of Corza Ophthalmology, a business unit dedicated to the advancement of global vision care. The company maintains a comprehensive portfolio of ophthalmic surgical products, ranging from advanced biologics and diagnostic lenses to precision-engineered surgical instruments. By integrating legacy brands such as Katena, Blink, and EagleVision, the organization provides a holistic suite of tools designed to support clinicians throughout the entire sight restoration pathway. Their market strategy emphasizes high-quality manufacturing and a deep commitment to improving patient outcomes through technological innovation in the ophthalmology space.
How much funding has Asico raised?
Asico has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Asico
PPP
Public-Private Partnership
What's next for Asico?
With the infusion of this latest capital, Asico is expected to prioritize the expansion of its surgical instrument pipeline and the enhancement of its diagnostic product offerings. The late-stage nature of this funding suggests a focus on scaling operational efficiencies and deepening market penetration within the global healthcare landscape. Future strategic initiatives will likely involve the integration of next-generation surgical technologies and the strengthening of supply chain capabilities to meet the increasing demand for high-fidelity ophthalmic devices. As the company continues to refine its sight restoration pathway, it remains a pivotal player in the medical technology ecosystem, poised for sustained growth and clinical impact.
See full Asico company page
